Universität Wien

323001 VU Introduction to Drug Discovery and Preclinical Drug Development - MPS1 (2019W)

5.00 ECTS (2.00 SWS), SPL 32 - Pharmazie
Continuous assessment of course work

Beginn am 01.10.2019 09.00 Uhr im Raum 2D313
Vorlesungstermine:
02.10./03.10./07.10./08.10./09.10./10.10./14.10./15.10./16.10./17.10./21.10./22.10.2019 immer von 14.00-17.00 Uhr im Raum 2D313

Details

Language: English

Lecturers

Classes (iCal) - next class is marked with N

  • Tuesday 01.10. 09:00 - 11:30 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
  • Wednesday 02.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
  • Thursday 03.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
  • Monday 07.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
  • Tuesday 08.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
  • Wednesday 09.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
  • Thursday 10.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
  • Monday 14.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
  • Tuesday 15.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
  • Wednesday 16.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
  • Thursday 17.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
  • Monday 21.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
  • Tuesday 22.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
  • Wednesday 23.10. 14:15 - 15:45 UZA2 Hörsaal 5 (Raum 2Z202) 2.OG

Information

Aims, contents and method of the course

The students will be introduced to basic principles in drug discovery. The course will consist of presentations given by the faculty, as well as presentations given by students, followed by round table discussions.

Assessment and permitted materials

There will be one written evaluation at the end of the course.
The grades will be deduced from the result in the written evaluation, together with taking into account class participation as well as presentation skills.
The written evaluation is done in the open book mode, i.e. students are allowed to use all the material collected during the class and the studies for the class.

Minimum requirements and assessment criteria

The student should possess basic knowledge in principles of drug discovery. Topics will cover target identification and validation, structural biology, hit identification and validation, lead structure identification and optimization and hereby be able to understand and comprehensively and critically present original papers / projects /ideas to these topics.

Examination topics

All topics covered during the course.

Reading list

Some useful literature can be found in the following publications:
- Benjamin E. Blass: Basic Principles of Drug Discovery and Development (Academic Press, ISBN 978-0-12-411508-8)
- Raymond Hill: Drug Discovery and Development: Technology in Transition (Churchill Livingstone Elsevier, ISBN 976-0-7020-4299-7)
- Jeffrey Strovel et al.: Early Drug Discovery and Development Guidelines: For Academic Researchers, Collaborators, and Start-up Companies (https://www.ncbi.nlm.nih.gov/books/NBK92015/pdf/Bookshelf_NBK92015.pdf)

Association in the course directory

Last modified: Sa 02.04.2022 00:27